VADOVATIONS, INC.

OKLAHOMA CITY, OK · Medtech · Private

Miniature implantable ventricular assist device (VAD) platform with interchangeable components for pediatric heart support

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Headquarters: OKLAHOMA CITY, OK
Latest Form D: $5M, Dec 2019
Total capital: $13M

Federal grants: $6M; 3 awards · 2015–2016; Rank in peer group#120 of 538
Private capital raised: $7M; 2 Form D · last Dec 2019; 83 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 12; 7 pending · first 2017; Rank in peer group#51 of 538

Capital timeline

Latest events

Dec 2019Private capital raisedForm D · SEC · 2nd filing$5M
Nov 2016Federal grantHealth and Human S · Phase II · Small blood pumps for small patients$3M
Aug 2016Federal grantHealth and Human S · Phase II · Regulatory Support Administrative Supplement for Development of a Pediatric Ventricular Assist Device$5K
Nov 2015Private capital raisedForm D · SEC · 1st filing$2M
Sep 2015Federal grantHealth and Human S · Phase II · Small blood pumps for small patients$3M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

2months

from VADOVATIONS, INC.’s first federal award to its first private round.

First federal award · Sep 2015: Health and Human S · $3M
First Form D · Nov 2015: $2M · 1st Form D
Awards before first raise: 1 award

An association in public records, not a cause or a prediction.

Standing among 538 peers

Line = median

Medtech · Device

Federal grants#120 · top 22%
Granted patents#51 · top 9%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

Allison E. PetersenExecutive OfficerNamed in SEC Form D filings
James W. LongExecutive Officer, DirectorNamed in SEC Form D filings
John B. FrickDirectorNamed in SEC Form D filings
John W. LongExecutive Officer, DirectorNamed in SEC Form D filings
Karl E. NelsonExecutive OfficerNamed in SEC Form D filings
Karl E. Nelson, R.N., M.B.A.Executive OfficerNamed in SEC Form D filings

Show all 12 people

Kathryn E. IngerlyExecutive OfficerNamed in SEC Form D filings
Kurt W. DasseExecutive Officer, DirectorNamed in SEC Form D filings
Lawrence C. BruceDirectorNamed in SEC Form D filings
Peter E. DulaneyDirectorNamed in SEC Form D filings
Stephen M. PrescottDirectorNamed in SEC Form D filings
Timothy E. PearsonDirectorNamed in SEC Form D filings

What it has protected

USPTO · 12 granted of 19

Aug 15, 2023GrantedHeart Assist DeviceUSPTOUS 11,724,093
Feb 28, 2023GrantedTissue Interface Apparatus, Systems, And MethodsUSPTOUS 11,589,896
Apr 19, 2022GrantedElectrical ConnectorUSPTOUS 11,309,662

Show all 19 patent records

Heart Assist DeviceAug 15, 2023 · US 11,724,093Granted
Tissue Interface Apparatus, Systems, And MethodsFeb 28, 2023 · US 11,589,896Granted
Electrical ConnectorApr 19, 2022 · US 11,309,662Granted
Heart Assist DeviceFeb 16, 2021 · US 10,918,774Granted
Electrical ConnectorJan 5, 2021 · US 10,886,663Granted
Tissue Interface Apparatus, Systems, And MethodsJan 5, 2021 · US 10,881,430Granted
Electrical ConnectorDec 1, 2020 · US 10,855,026Granted
Electrical ConnectorNov 10, 2020 · US 10,833,451Granted
Electrical ConnectorAug 11, 2020 · US 10,741,968Granted
Electrical ConnectorNov 19, 2019 · US 10,483,690Granted
Coring Dilator For Defining An Aperture In A Tissue WallOct 29, 2019 · US 10,456,167Granted
Heart Assist DeviceAug 22, 2017 · US 9,737,651Granted
Coring Dilator For Defining An Aperture In A Tissue WallApplication PCTUS2014049457Pending
Ventricular Assist System and Method of Treatment of Cardiovascular ImpairmentApplication 63426957Pending
Electrical ConnectorApplication PCTUS2019060623Pending
Tissue Interface Apparatus, Systems And MethodsApplication PCTUS2019026761Pending
Heart Assist DeviceApplication PCTUS2018012736Pending
Heart Assist DeviceApplication PCTUS2016030445Pending
System and Method of Treating Cardiovascular ImpairmentApplication 63489607Pending

Harpoon Medical, Inc.Similar federal contract value in Medtech · null in contracts
VASOPTIC MEDICAL, INC.Similar federal contract value in Medtech · null in contracts
Nupulsecv IncSimilar federal contract value in Medtech · null in contracts
ABREOS BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts
SENAPTEC INC.Similar federal contract value in Medtech · null in contracts
NXT BIOMEDICAL, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.